Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencySat, 06 Jul 2024 13:31:49 +0200Wed, 24 Jan 2024 13:26:00 +0100Human medicines European public assessment report (EPAR): Rezzayo, rezafungin, Date of authorisation: 22/12/2023, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/rezzayoHuman medicines European public assessment report (EPAR): Rezzayo, rezafungin, Date of authorisation: 22/12/2023, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/rezzayoWed, 24 Jan 2024 13:26:00 +0100Human medicineRezzayo : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5900-en.pdfRezzayo : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5900-en.pdfWed, 24 Jan 2024 11:46:46 +0100Human medicine